![](/img/cover-not-exists.png)
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
Motzer, Robert J, Hutson, Thomas E, Glen, Hilary, Michaelson, M Dror, Molina, Ana, Eisen, Timothy, Jassem, Jacek, Zolnierek, Jakub, Maroto, Jose Pablo, Mellado, Begoña, Melichar, Bohuslav, Tomasek, JiVolume:
16
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/s1470-2045(15)00290-9
Date:
November, 2015
File:
PDF, 381 KB
english, 2015